Pancreatic Cancer Research

ResearcherAmerican University of Beirut Medical CenterActive in the last 2 years

Ali I. Shamseddine

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3725-8403; OpenAlex author ID A5073707067. Sources: OpenAlex.

Their work

Papers
14 (first author 1, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
22
Papers, trials and grants by year

2012: 2 papers · 2013: 2 papers · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 3 papers

Papers 14

  1. Clinicopathological and Prognostic Implications of Epithelial-to-Mesenchymal Transition-Related Immunohistochemical Markers in Resectable Pancreatic Cancer: A … Last author DOI 10.1002/cnr2.70565↗
  2. Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma: from Tumor Biology to Biomarker-Guided Strategies. Last author DOI 10.1007/s11912-026-01812-4↗
  3. Efficacy and Safety of Modified GTX as Second-Line Therapy in Advanced Pancreatic Adenocarcinoma: A Prospective Cohort Study. Co-author DOI 10.1007/s12029-026-01504-z↗
  4. Pre-Operative Markers of Post-Operative Complications in Pancreatic Cancer Patients: A Single-Center Study. Last author DOI 10.1007/s44197-025-00371-4↗
  5. An Atypical Case of Pancreatic Cancer with Mesenchymal Differentiation in a Patient with Primary Lung Adenocarcinoma: Insights into Tumor Biology and Novel The… Last author DOI 10.3390/diagnostics14222512↗
  6. Maintenance chemotherapy in advanced and metastatic pancreatic cancer, a narrative review and case series. Last author DOI 10.1111/ajco.13912↗
  7. Neo-adjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma. Last author DOI 10.1111/ajco.13775↗
  8. CYR61/CCN1 expression in resected pancreatic ductal adenocarcinoma: A retrospective pilot study of the interaction between the tumors and their surrounding mic… Co-author DOI 10.1016/j.heliyon.2020.e03842↗
  9. Ki67 and P53 in Relation to Disease Progression in Metastatic Pancreatic Cancer: a Single Institution Analysis. First author DOI 10.1007/s12253-018-0464-y↗
  10. Modified GTX as second-line therapy for advanced pancreatic adenocarcinoma. Last author DOI 10.1007/s12029-013-9571-x↗
  11. Management of a patient diagnosed with pancreatic cancer and myelodysplastic syndrome. Co-author PMID 23745160↗
  12. Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer. Co-author PMID 24147159↗
  13. Communication and palliative care in a 64-year-old man with pancreatic adenocarcinoma. Co-author PMID 23077687↗
  14. Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma. Co-author PMID 23112885↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sally Naji Temraz · 9 shared papers, 2012–2026 · strength 1.50
  2. Noura Abbas · 3 shared papers, 2024–2026 · strength 0.95
  3. Walid Ghazi Faraj · 5 shared papers, 2012–2026 · strength 0.55
  4. Laudy Chehade · 2 shared papers, 2023–2026 · strength 0.44
  5. Layal Al Mahmasani · 1 shared paper, 2026 · strength 0.43
  6. Sara El Meski · 1 shared paper, 2026 · strength 0.36
  7. Ghassan K. Abou‐Alfa · 5 shared papers, 2012–2022 · strength 0.26
  8. Eileen Mary O'Reilly · 5 shared papers, 2012–2022 · strength 0.26
  9. Ahmad Machmouchi · 1 shared paper, 2026 · strength 0.24
  10. Haifa Dbouk · 2 shared papers, 2013–2022 · strength 0.17
  11. Fadi Farhat · 1 shared paper, 2022 · strength 0.14
  12. Wassim G. Abou-Kheir · 1 shared paper, 2020 · strength 0.10
  13. Samer Nassif · 1 shared paper, 2019 · strength 0.10
  14. Leonard B. Saltz · 3 shared papers, 2012–2013 · strength 0.09
  15. Hana Ajouz · 2 shared papers, 2013–2014 · strength 0.07
  16. David Paul Kelsen · 2 shared papers, 2012–2013 · strength 0.06
  17. Elizabeth S. Won · 1 shared paper, 2013 · strength 0.03
  18. Kenneth H. Yu · 1 shared paper, 2013 · strength 0.03
  19. Celina Ang · 1 shared paper, 2012 · strength 0.03
  20. Andrew S. Epstein · 1 shared paper, 2012 · strength 0.03
  21. Maeve Aine Lowery · 1 shared paper, 2012 · strength 0.03
  22. Alexandra Snyder · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.